Heidi Penttinen

700 total citations
15 papers, 450 citations indexed

About

Heidi Penttinen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Heidi Penttinen has authored 15 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Heidi Penttinen's work include Cancer survivorship and care (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Cancer-related cognitive impairment studies (4 papers). Heidi Penttinen is often cited by papers focused on Cancer survivorship and care (8 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Cancer-related cognitive impairment studies (4 papers). Heidi Penttinen collaborates with scholars based in Finland, France and Latvia. Heidi Penttinen's co-authors include Matti Virkkunen, Tiina Saarto, Carl Blomqvist, Riku Nikander, Leena Vehmanen, Meri Utriainen, Riikka Huovinen, Hannu Kautiainen, Harri Sievänen and Riitta Luoto and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Urology.

In The Last Decade

Heidi Penttinen

15 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidi Penttinen Finland 10 252 123 101 63 49 15 450
André Liebmann Germany 7 194 0.8× 68 0.6× 98 1.0× 32 0.5× 63 1.3× 12 520
Julia Hamer Canada 6 254 1.0× 92 0.7× 69 0.7× 54 0.9× 24 0.5× 9 419
Aina Emaus Norway 11 219 0.9× 58 0.5× 69 0.7× 122 1.9× 42 0.9× 15 551
Janice J. Twiss United States 12 304 1.2× 47 0.4× 95 0.9× 97 1.5× 32 0.7× 19 485
Scott Capozza United States 6 310 1.2× 78 0.6× 88 0.9× 78 1.2× 26 0.5× 12 399
Nancy Waltman United States 16 370 1.5× 53 0.4× 106 1.0× 147 2.3× 58 1.2× 35 649
Brenton J. Baguley Australia 12 208 0.8× 84 0.7× 60 0.6× 233 3.7× 40 0.8× 36 535
Kirsty Rickett Australia 9 115 0.5× 49 0.4× 60 0.6× 24 0.4× 49 1.0× 13 335
Nathalie Sami United States 11 478 1.9× 128 1.0× 143 1.4× 309 4.9× 49 1.0× 17 760
Jennifer Ose United States 11 145 0.6× 52 0.4× 42 0.4× 253 4.0× 50 1.0× 38 580

Countries citing papers authored by Heidi Penttinen

Since Specialization
Citations

This map shows the geographic impact of Heidi Penttinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi Penttinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi Penttinen more than expected).

Fields of papers citing papers by Heidi Penttinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi Penttinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi Penttinen. The network helps show where Heidi Penttinen may publish in the future.

Co-authorship network of co-authors of Heidi Penttinen

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi Penttinen. A scholar is included among the top collaborators of Heidi Penttinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi Penttinen. Heidi Penttinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Blomqvist, Carl, Leena Vehmanen, Pirkko‐Liisa Kellokumpu‐Lehtinen, et al.. (2024). Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study. Breast Cancer Research and Treatment. 206(1). 57–65. 1 indexed citations
4.
Roine, Eija, Harri Sintonen, Pirkko‐Liisa Kellokumpu‐Lehtinen, et al.. (2020). Health-related Quality of Life of Breast Cancer Survivors Attending an Exercise Intervention Study: A Five-year Follow-up. In Vivo. 34(2). 667–674. 19 indexed citations
5.
Penttinen, Heidi, Meri Utriainen, Pirkko‐Liisa Kellokumpu‐Lehtinen, et al.. (2019). Effectiveness of a 12-month Exercise Intervention on Physical Activity and Quality of Life of Breast Cancer Survivors; Five-year Results of the BREX-study. In Vivo. 33(3). 881–888. 54 indexed citations
6.
Massard, Christophe, Heidi Penttinen, Egils Vjaters, et al.. (2015). Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study. European Urology. 69(5). 834–840. 48 indexed citations
7.
Massard, Christophe, Heidi Penttinen, Petri Bono, et al.. (2015). Pharmacokinetics, activity, and safety of ODM-201 in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: An open-label phase I trial with long-term extension.. Journal of Clinical Oncology. 33(7_suppl). 230–230. 1 indexed citations
8.
Penttinen, Heidi, Risto P. Roine, Tiina Jahkola, et al.. (2014). Quality of life of recently treated patients with breast cancer.. PubMed. 34(3). 1201–6. 10 indexed citations
9.
Massard, Christophe, Teuvo L.J. Tammela, Egils Vjaters, et al.. (2014). A study of two ODM-201 formulations with a safety and tolerability extension phase in patients with metastatic chemotherapy-naive castration-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 32(4_suppl). 115–115. 5 indexed citations
10.
Elme, Anneli, Meri Utriainen, T Palva, et al.. (2013). Obesity and physical inactivity are related to impaired physical health of breast cancer survivors.. PubMed. 33(4). 1595–602. 12 indexed citations
11.
Saarto, Tiina, Harri Sievänen, Pirkko Kellokumpu‐Lehtinen, et al.. (2011). Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial. Osteoporosis International. 23(5). 1601–1612. 68 indexed citations
12.
Penttinen, Heidi, Tiina Saarto, Pirkko Kellokumpu‐Lehtinen, et al.. (2010). Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments. Psycho-Oncology. 20(11). 1211–1220. 84 indexed citations
13.
Saarto, Tiina, Heidi Penttinen, Harri Sievänen, et al.. (2010). Abstract PD08-07: The Impact of 1-Year Supervised Exercise Training on Physical Performance and Quality of Life of Breast Cancer Patients — A Randomise Prospective Phase III Trial. Cancer Research. 70(24_Supplement). PD08–7. 1 indexed citations
14.
Penttinen, Heidi, Riku Nikander, Carl Blomqvist, Riitta Luoto, & Tiina Saarto. (2009). Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible. Contemporary Clinical Trials. 30(5). 457–463. 22 indexed citations
15.
Virkkunen, Matti & Heidi Penttinen. (1984). Serum cholesterol in aggressive conduct disorder: a preliminary study.. PubMed. 19(3). 435–9. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026